Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schultz

Showing results (551-560 of 563) with videos related to

Pageof 57
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2024
DICER1-Related Tumor Predisposition: Identification of At-risk Individuals and Recommended Surveillance StrategiesKris Ann P Schultz, Alexander T Nelson, Paige H R Mallinger, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Rethinking the residual approach: Leveraging machine learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Acta Neuropathologica|December 11, 2019
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry studyBryan K Li, Alexandre Vasiljevic, Christelle Dufour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2025
Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor PredispositionPeter N Fiorica, Lisa Golmard, Jung Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
The prognostic value of blood-based p-tau217 levels on progression to clinical impairmentRachel F Buckley, Diana L Townsend, Colin J Birkenbihl, et al.
JAMA Neurology|July 30, 2014
Functional connectivity in autosomal dominant and late-onset Alzheimer diseaseJewell B Thomas, Matthew R Brier, Randall J Bateman, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Nature Medicine|November 6, 2019
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case reportJoseph F Arboleda-Velasquez, Francisco Lopera, Michael O'Hare, et al.
JAMA Neurology|October 16, 2023
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer DiseaseZahra Shirzadi, Stephanie A Schultz, Wai-Ying W Yau, et al.
Aging Cell|June 9, 2023
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's diseaseStephanie A Schultz, Zahra Shirzadi, Aaron P Schultz, et al.
Pageof 57

Showing results (551-560 of 563) with videos related to

Sort By:
Pageof 57
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2024
DICER1-Related Tumor Predisposition: Identification of At-risk Individuals and Recommended Surveillance StrategiesKris Ann P Schultz, Alexander T Nelson, Paige H R Mallinger, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Rethinking the residual approach: Leveraging machine learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Acta Neuropathologica|December 11, 2019
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry studyBryan K Li, Alexandre Vasiljevic, Christelle Dufour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2025
Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor PredispositionPeter N Fiorica, Lisa Golmard, Jung Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
The prognostic value of blood-based p-tau217 levels on progression to clinical impairmentRachel F Buckley, Diana L Townsend, Colin J Birkenbihl, et al.
JAMA Neurology|July 30, 2014
Functional connectivity in autosomal dominant and late-onset Alzheimer diseaseJewell B Thomas, Matthew R Brier, Randall J Bateman, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Nature Medicine|November 6, 2019
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case reportJoseph F Arboleda-Velasquez, Francisco Lopera, Michael O'Hare, et al.
JAMA Neurology|October 16, 2023
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer DiseaseZahra Shirzadi, Stephanie A Schultz, Wai-Ying W Yau, et al.
Aging Cell|June 9, 2023
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's diseaseStephanie A Schultz, Zahra Shirzadi, Aaron P Schultz, et al.
Pageof 57